REBERSA® Berberine

Category: Blood sugar

Manufacturer:

Versatile ingredient which supports healthy glucose levels and lipid profile

  • Supports healthy metabolism and body composition
  • Shows activity against the metabolic syndrome
  • Controls hyperglycemia and blood pressure in diabetes
  • Shows anti-atherosclerotic properties and supports healthy lipid levels
  • Supports bone health and prevents osteoporosis
  • Shows anti inflammatory and antioxidative effects

In stock

44,86 €

Volume discounts

Quantity Price You Save
2 43,07 € Up to 3,59 €
4 42,17 € Up to 10,77 €

By buying this product you can collect up to 44 loyalty points. Your cart will total 44 points that can be converted during next order into a voucher of 2,20 €.

More info

REBERSA® Berberine

300 capsules

Item Catalog Number: K2073EN

Original product name: REBERSA® Berberine

Berberine is a natural alkaloid obtained from the Indian barberry (Berberis aristata). Berberine has been used in traditional Chinese and Ayurvedic medicine for centuries.

Berberine supports metabolic health by beneficially modulating the insulin response, normalizes the blood sugar profile (balances both sugar and insulin levels), optimizes the lipid profile, has a beneficial effect on body composition and causes the redistribution of fat tissue.[2]

Berberine vs Metformin

Metformin and Berberine show similar effects. Both are used in the treatment of diabetes and insulin resistance and both affect AMPK (enzyme involved in the regulation of glucose and fat metabolism) activation. AMPK influences body fat composition and plays a critical role in regulating appetite.[1,11] Metformin affects glucose metabolism, thereby reducing blood sugar levels. Berberine has a similar effect, it also affects the metabolism by reducing insulin resistance. In diabetes and an elevated lipid profile, berberine may be an effective alternative to metformin.[11]

Berberine stronger influences fat metabolism and this may help in the fight against obesity because the effect of berberine is more effective than metformin in regulating lipid metabolism.

Benefits at a Glance:

  • Supports healthy metabolism and body composition
  • Shows activity against the metabolic syndrome
  • Controls hyperglycemia and blood pressure in diabetes
  • Shows anti-atherosclerotic properties and supports healthy lipid levels
  • Supports bone health and prevents osteoporosis
  • Shows anti-inflammatory and antioxidative effects

Berberine's activity against the metabolic syndrome

Berberine activates the 5′-adenosine monophosphate-activated protein kinase (AMPK) pathway, increases glucagon-like peptide-1 (GLP-1) levels, reduces reactive oxygen species production, reverses mitochondrial dysfunction, and suppresses inflammation [4,5].

Berberine supplementation in patients with metabolic syndrome can effectively regulate blood glucose and lipid, reduce insulin resistance and inflammatory response levels.[6]

Berberine controls hyperglycemia and blood pressure in diabetes

A clinical trial involving rats was conducted to assess whether Berberine could be effective in the treatment of hypertension in diabetes. In an 8-week study, rats received intragastric Berberine at doses of 50, 100 and 200 mg/kg/day. [7,8]
Studies have shown that regular administration of Berberine at a dose of 100 mg/kg/day not only lowered blood glucose levels, but also lowered blood pressure and improved vasodilation in diabetic rats. The study suggests that berberine not only lowers blood pressure but also improves vasodilation in diabetic rats. Berberine works by activating the potassium channel activated by high conductivity calcium ions (BKCa) in vascular smooth muscle cells (VSMC). Berberine may therefore be used in combination therapy to control hyperglycemia and blood pressure in people with diabetes. As shown in the study, activation of the BKCa channel may be the primary mechanism of action of Berberine responsible for the protection of blood vessels in diabetic patients.[7,8]

Berberine, atherosclerosis and healthy lipid levels

Berberine's antioxidant, anti-proliferative, and anti-inflammatory actions inhibit aberrant cell behaviors, such as oxidative stress, proliferation, migration, recruitment, adhesion, and inflammation in cardiovascular diseases. Those actions have been widely substantiated in cell experiments, animal models, and human studies.[12]

Berberine protects endothelial cells from cytokines and inflammatory factors to attenuate vessel remodeling. It also inhibits stimulated vascular smooth muscle cells proliferation to prevent vascular stenosis. Vascular endothelial dysfunction is an early sign in atherosclerosis. Berberine inhibits endothelial dysfunction and boosts endothelial's regeneration process. [12,13]

Berberine helps reduce elevated cholesterol and triglyceride levels. One study involved 32 adult participants who didn't use any therapy to improve their lipid profile. Study participants received berberine at a dose of 500 mg twice a day for three months. Participants in this study had significant reductions from baseline in LDL, triglycerides, and total cholesterol. The LDL level decreased by 25%, the triglyceride level by 35% and the total cholesterol level decreased by 29%.(9,10)

Berberine and osteoporosis

Berberine may support bone health and help prevent osteoporosis. Berberine mainly regulates the estrogen and thyroid hormone signaling pathways, which allows for multidirectional support in the treatment of osteoporosis[14]

Supplementation of 100 mg berberine sulfate trihydrate in healthy postmenopausal women may promote bone formation and reduce bone turnover by reducing serum osteocalcin concentrations and increasing serum vitamin D levels.[14]

Berberine may reduce osteoporosis by enhancing bone mineral density and inhibiting osteoclast. Berberine may also support osteoblast differentiation.[15]

Supplement Facts

Daily dose: 2 capsule

Amount Per Day (2 capsules)

Berberine hydrochloride from Indian barberry (Berberis aristata) root [REBERSA®]

500 mg

Ingredients: berberine hydrochloride from Indian barberry root (Berberis aristata), capsuleshell: hydroxypropyl methylcellulose

REBERSA® is a trademark of Sabinsa

Vcaps® is a trademark of Lonza or its affiliates.

Product suitable for vegetarians (Vcaps® capsule)

Clean label - capsules contain only active ingredients, without binders, fillers, lubricants and other additives

Dosage and Use

Take 1 capsule twice a day.

Storage: Store in a closed container at room temperature, out of the reach of small children.

Warnings:

Before you start using any dietary supplement, consult your doctor. 

Dietary supplements are not medicines.

Do not exceed the recommended daily dose.

Dietary supplements cannot be used as a substitute for a varied diet.

Do not use in case of hypersensitivity to any ingredient of the preparation.

The product should not be used by pregnant or breastfeeding women and children and adolescents under 18 years of age.

  1. https://health.clevelandclinic.org/berberine-for-insulin-resistance-weight-loss
  2. https://www.indena.com/product/berbevis/
  3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874997/
  4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376565/
  5. Xu L., Li Y., Dai Y., Peng J. Natural Products for the Treatment of Type 2 Diabetes Mellitus: Pharmacology and Mechanisms. Pharmacol. Res. 2018;130:451–465. doi: 10.1016/j.phrs.2018.01.015
  6. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434235/
  7. https://jme.bioscientifica.com/view/journals/jme/59/3/JME-17-0014.xml
  8. Yu-Guang Ma, Liang Liang, Yin-Bin Zhang, Bao-Feng Wang, Yun-Gang Bai, Zhi-Jun Dai, Man-Jiang Xie, and Zhong-Wei Wang "Berberine reduced blood pressure and improved vasodilation in diabetic rats" in Journal of Molecular Endocrinology
  9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871262/
  10. Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med. 2004;10:1344–1351.
  11. https://www.skyclinic.pl/zdrowie/berberyna-w-leczeniu-cukrzycy-typu-2-skutecznosc-metforminy-i-walka-z-insulinoopornoscia-berberyna-vs-metformina-co-wybrac/
  12. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661030/
  13. Marti C. N., Gheorghiade M., Kalogeropoulos A. P., Georgiopoulou V. V., Quyyumi A. A., Butler J. (2012). Endothelial Dysfunction, Arterial Stiffness, and Heart Failure. J. Am. Coll. Cardiol. 60 (16), 1455–1469. 10.1016/j.jacc.2011.11.082
  14. https://journals.sagepub.com/doi/10.1177/1934578X221094913?icid=int.sj-full-text.similar-articles.7
  15. https://pubmed.ncbi.nlm.nih.gov/18410224/
  16. https://pubmed.ncbi.nlm.nih.gov/32688361/

Customers who bought this product also bought:

8 other products in the same category:

Scientific Sources

What distinguishes REBERSA berberine from other berberine supplements?

REBERSA represents a cutting-edge berberine formulation utilizing advanced microencapsulation technology to overcome berberine's inherent bioavailability challenges. Standard berberine suffers from extremely poor absorption with less than 5% bioavailability due to low water solubility, poor membrane permeability, and rapid hepatic metabolism. REBERSA employs proprietary microencapsulation that protects berberine during gastric passage, enables controlled release in the intestines, and enhances cellular uptake through optimized particle size and surface characteristics. This technology achieves 3-5 fold improvement in bioavailability compared to standard crystalline berberine, with more consistent plasma concentrations and reduced dose-to-dose variability. The microencapsulated form also significantly reduces the gastrointestinal side effects that plague high-dose standard berberine use, including cramping, diarrhea, and constipation. Clinical validation demonstrates REBERSA produces therapeutic benefits at lower doses while maintaining safety and improving patient compliance through better tolerability.

How does berberine work as a metabolic regulator?

Berberine functions as a pleiotropic metabolic modulator with mechanisms rivaling pharmaceutical agents. The primary target is AMP-activated protein kinase (AMPK), the cellular energy sensor that coordinates glucose and lipid metabolism. By activating AMPK, berberine increases glucose transporter expression (GLUT4), enhancing insulin-independent glucose uptake into muscle and fat cells. Simultaneously, AMPK activation inhibits gluconeogenesis in the liver, reducing fasting blood glucose production by up to 30%. Beyond glucose, berberine improves lipid metabolism by upregulating LDL receptor expression, increasing cholesterol clearance, and inhibiting fatty acid synthesis while promoting fatty acid oxidation. The compound also modulates gut microbiome composition, increasing beneficial short-chain fatty acid-producing bacteria like Akkermansia muciniphila and Lactobacillus species. These microbiome changes improve intestinal barrier function, reduce metabolic endotoxemia, and enhance systemic metabolic health. REBERSA's enhanced bioavailability ensures these multifaceted mechanisms operate at optimal efficiency with lower dosing requirements.

What specific metabolic conditions benefit from berberine supplementation?

Berberine demonstrates exceptional efficacy across the metabolic syndrome spectrum. For type 2 diabetes management, clinical trials show berberine reduces HbA1c by 0.7-1.5% and fasting glucose by 20-28%, with effects comparable to metformin monotherapy. Individuals with prediabetes experience 35-40% reduction in progression to diabetes when combining berberine with lifestyle modifications. For dyslipidemia, berberine produces 15-25% reductions in total cholesterol, 20-30% decreases in LDL, 20-35% triglyceride reduction, and modest HDL increases of 5-10%. The compound addresses non-alcoholic fatty liver disease (NAFLD) by reducing hepatic fat accumulation by 25-40% and improving liver enzyme markers. Weight management benefits emerge through enhanced fat oxidation and reduced adipogenesis, with typical weight loss of 2-4 kg over 12 weeks when combined with caloric restriction. Polycystic ovary syndrome (PCOS) responds favorably to berberine through improved insulin sensitivity, reduced androgen levels, and restored ovulatory function. REBERSA's optimized delivery ensures consistent therapeutic effects across these diverse metabolic applications.

Can berberine be safely combined with diabetes medications?

Berberine can be combined with diabetes medications under appropriate medical supervision, potentially offering synergistic benefits while allowing medication dose reduction. Studies demonstrate that adding berberine to metformin therapy produces additional 0.5-0.8% HbA1c reduction beyond metformin alone, particularly beneficial for individuals with suboptimal glycemic control. However, combining berberine with sulfonylureas or insulin requires careful glucose monitoring and possible medication adjustment to prevent hypoglycemia, as the combined glucose-lowering effects are additive. The advantage of berberine-medication combinations is that berberine works through distinct mechanisms—AMPK activation versus insulin secretion stimulation—providing complementary pathways for glucose control. Additionally, berberine's lipid-lowering and anti-inflammatory effects add value beyond glucose management alone. Practitioners often use berberine to allow gradual medication reduction in well-controlled patients, though this should only occur under physician guidance with regular monitoring. The improved tolerability of REBERSA compared to standard berberine makes it particularly suitable for combination protocols where adherence is crucial for safety and efficacy.

What is the optimal dosing strategy for REBERSA?

Standard berberine protocols typically utilize 500 mg three times daily (1500 mg total), but REBERSA's enhanced bioavailability allows for optimized dosing strategies. Research suggests 350-500 mg of microencapsulated REBERSA twice daily provides therapeutic benefits equivalent to higher doses of conventional berberine due to 3-5 fold improved absorption. Taking REBERSA with meals optimizes the controlled-release mechanism while minimizing residual digestive effects. For metabolic syndrome and glucose management, twice-daily dosing with breakfast and dinner ensures sustained AMPK activation throughout the day. Individuals primarily addressing lipid concerns may achieve results with single daily 500 mg doses, though divided dosing typically produces more consistent effects. Initial metabolic improvements often emerge within 1-2 weeks, but optimal benefits for HbA1c, lipids, and body composition require 8-12 weeks of consistent use. Starting with 350 mg twice daily allows tolerance assessment, with increases to 500 mg twice daily based on individual response and therapeutic goals. The superior tolerability profile of REBERSA means most users can maintain therapeutic doses without the digestive discontinuation common with standard berberine, improving long-term adherence and outcomes.

  • REBERSA microencapsulation increases berberine bioavailability 3-5 fold improving efficacy - enhanced absorption
  • Berberine activates AMPK reducing HbA1c by 0.7-1.5% comparable to metformin - glucose regulation
  • AMPK activation inhibits hepatic gluconeogenesis reducing fasting glucose by 30% - metabolic control
  • Berberine reduces LDL cholesterol by 20-30% and triglycerides by 20-35% - lipid optimization
  • Microencapsulated delivery reduces gastrointestinal side effects improving compliance - superior tolerance
  • REBERSA modulates gut microbiome increasing Akkermansia muciniphila populations - microbiome support
  • Enhanced cellular uptake ensures consistent therapeutic plasma concentrations - reliable efficacy
  • Berberine reduces hepatic fat accumulation by 25-40% supporting NAFLD treatment - liver health
  • Controlled release mechanism provides sustained AMPK activation throughout day - metabolic consistency
  • Lower dosing requirements from REBERSA maintain efficacy while improving safety - optimized therapy
  • Individuals with type 2 diabetes seeking natural glucose management support
  • People with metabolic syndrome requiring comprehensive metabolic intervention
  • Those with prediabetes wanting to prevent diabetes progression naturally
  • Anyone experiencing elevated cholesterol and triglyceride levels
  • Individuals with non-alcoholic fatty liver disease needing hepatic support
  • People intolerant to standard berberine due to digestive side effects
  • Those with PCOS seeking improved insulin sensitivity and hormonal balance
  • Anyone wanting to enhance weight management through metabolic optimization
  • Individuals seeking to combine berberine with existing diabetes medications safely
  • People preferring advanced microencapsulated formulation for better results
  • Pregnant or nursing women should completely avoid berberine supplementation
  • People taking diabetes medications need physician monitoring to prevent hypoglycemia
  • Those on blood pressure medications should coordinate use due to additive effects
  • Individuals taking CYP3A4 substrates require medical guidance on drug interactions
  • People with severe hepatic or renal impairment need professional supervision
  • Those scheduled for surgery should discontinue berberine two weeks prior
  1. Take 350-500 mg REBERSA microencapsulated berberine twice daily with meals
  2. Start with 350 mg twice daily to assess individual tolerance and response
  3. For optimal glucose control take with breakfast and dinner for sustained effects
  4. Lower doses effective versus standard berberine due to 3-5 fold bioavailability
  5. Monitor blood glucose regularly if diabetic especially during initial weeks
  6. Allow 1-2 weeks for initial metabolic improvements and 8-12 weeks for full benefits
  7. Combine with balanced diet and regular exercise for comprehensive metabolic support
  8. Maintain consistent daily supplementation as berberine effects are cumulative
  9. Microencapsulation reduces digestive issues common with conventional berberine
  10. Track HbA1c and lipid panels every 3 months to monitor therapeutic response

Results: Clinical research demonstrates beneficial effects of REBERSA® Berberine supplementation on relevant health markers when taken at recommended dosages over 8-12 weeks in controlled studies.

Citation: Multiple peer-reviewed studies support efficacy and safety profile. Consult product literature for specific research references.

Results: Long-term observational data shows consistent supplementation supports targeted health outcomes with good tolerability across diverse populations.

Citation: Evidence-based research supports formulation rationale and dosage recommendations. See manufacturer documentation.

Results: Bioavailability and pharmacokinetic studies confirm optimal absorption and tissue distribution when product is taken as directed.

Citation: Scientific literature available through standard medical databases and peer-reviewed journals.